These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

36 related articles for article (PubMed ID: 3428968)

  • 1. Lipid levels in subjects with impaired glucose tolerance.
    Ranga Rao KV; Seshiah V; Moses SG
    Indian J Med Res; 1987 Sep; 86():343-6. PubMed ID: 3428968
    [No Abstract]   [Full Text] [Related]  

  • 2. Postprandial lipaemia in patients with impaired fasting glucose, impaired glucose tolerance and diabetes mellitus.
    Madhu SV; Kant S; Srivastava S; Kant R; Sharma SB; Bhadoria DP
    Diabetes Res Clin Pract; 2008 Jun; 80(3):380-5. PubMed ID: 18321605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipid profile and its relation to fasting insulin level in non-insulin dependent diabetes mellitus (NIDDM).
    Uddin F; Miah AK
    Bangladesh Med Res Counc Bull; 1995 Aug; 21(2):64-72. PubMed ID: 8815864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum lipid and hsCRP levels in prediabetes--impaired fasting glucose (IFG) and impaired glucose tolerance (IGT).
    Chakarova N; Tankova T; Atanassova I; Dakovska L
    Diabetes Res Clin Pract; 2009 Oct; 86(1):56-60. PubMed ID: 19674805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum lipid levels in subjects with impaired glucose tolerance.
    Puavilai G; Tanphaichitr V; Banphotkasem S; Supitak V; Asawkul W; Sriphrapradaeng A
    J Med Assoc Thai; 1988 May; 71(5):262-8. PubMed ID: 3294328
    [No Abstract]   [Full Text] [Related]  

  • 6. Metabolic abnormalities in offspring of NIDDM patients with a family history of diabetes mellitus.
    Migdalis IN; Zachariadis D; Kalogeropoulou K; Nounopoulos C; Bouloukos A; Samartzis M
    Diabet Med; 1996 May; 13(5):434-40. PubMed ID: 8737025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Lipid changes in elderly subjects with non-insulin-dependent diabetes mellitus].
    Figueira JL; De Carvalho Filho ET; Netto MP; Pasini U; Grandjean-Thomsen YL; Andriolo A
    Rev Paul Med; 1988; 106(2):89-94. PubMed ID: 3238272
    [No Abstract]   [Full Text] [Related]  

  • 8. A 25-year follow-up study of glucose tolerance in first-degree relatives of type 2 diabetic patients: association of impaired or diabetic glucose tolerance with other components of the metabolic syndrome.
    Nauck MA; Meier JJ; Wolfersdorff AV; Tillil H; Creutzfeldt W; Köbberling J
    Acta Diabetol; 2003 Dec; 40(4):163-72. PubMed ID: 14740275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypertriglyceridaemic waist phenotype and β-cell function in subjects with normal and impaired glucose tolerance.
    Bardini G; Dicembrini I; Pala L; Cresci B; Rotella CM
    Diabet Med; 2011 Oct; 28(10):1229-33. PubMed ID: 21923697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [HDL cholesterol in diabetes mellitus type II].
    Valesano G; Magnacca M
    Minerva Med; 1989 Mar; 80(3):261-4. PubMed ID: 2717046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Correlation of plasma lipids and microproteinuria in diabetes mellitus].
    Häncu N; Zurro Hernández J; Debán Miguel C; Dutu AL; Veresiu IA; Lobón Cerviá C; Villar A; Suciu I; Mösler R
    Rev Clin Esp; 1991 Oct; 189(6):257-9. PubMed ID: 1763208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Lipid parameters in newly detected type II diabetic patients and relations to coronary heart disease].
    Häntzschel U; Wurlitzer M; Kuhfahl E; Dempe A
    Z Gesamte Inn Med; 1987 Oct; 42(20):571-5. PubMed ID: 3433844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of inorganic chromium and brewer's yeast supplementation on glucose tolerance, serum lipids and drug dosage in individuals with type 2 diabetes.
    Bahijiri SM; Mira SA; Mufti AM; Ajabnoor MA
    Saudi Med J; 2000 Sep; 21(9):831-7. PubMed ID: 11376359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of whole buckwheat (Fagopyrum esculentum) flour supplementation on lipid profile & glucose tolerance.
    Bijlani RL; Gandhi BM; Gupta MC; Manocha S; Tandon BN
    Indian J Med Res; 1985 Feb; 81():162-8. PubMed ID: 2989169
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effect of glibenclamide on lipid metabolism in non-insulin-dependent diabetic patients].
    Ratzmann KP; Schimke E; Herrmann C; Borngräber G; Meusel K
    Z Gesamte Inn Med; 1988 Mar; 43(5):122-4. PubMed ID: 3133890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating lipids and cardiovascular risk in newly diagnosed non-insulin-dependent diabetic subjects in India.
    Shelgikar KM; Naik SS; Khopkar M; Bhat DS; Raut KN; Joglekar CV; Gerard ME; Yajnik CS
    Diabet Med; 1997 Sep; 14(9):757-61. PubMed ID: 9300225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term evaluation of lipid profile and oral glucose tolerance test in Norplant users.
    Araujo FF; de Lima GR; Guazzelli CA; Barbieri M; Vigorito NM; Lindsey PC; Baracat EC
    Contraception; 2006 Apr; 73(4):361-3. PubMed ID: 16531167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Changes in carbohydrate and lipid metabolism in obesity].
    Actis Dato SM; Pittana J; Costa Gil JE; Nieto RE
    Medicina (B Aires); 1986; 46(6):677-85. PubMed ID: 3306255
    [No Abstract]   [Full Text] [Related]  

  • 19. Red blood cell lipid alterations in type II diabetes mellitus.
    Prisco D; Paniccia R; Coppo M; Vanni D; Rogasi PG; Tramontana M; Abbate R; Gensini GF
    Thromb Res; 1989 Jun; 54(6):751-8. PubMed ID: 2781513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An effective approach to lipid improvement in poorly controlled noninsulin dependent diabetes mellitus.
    Campbell LV; Barth R; Gosper J; Chisholm DJ
    Diabetes Educ; 1988; 14(3):235. PubMed ID: 3371172
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.